The Leading

Platform

for Long Read Genomics

Transform raw long-read sequencing data into actionable insights — from structural variants to repeat regions — at scale for research, diagnostics and drug discovery.

A spin-off from:

Published in:

Our Platform covers variant detection, prioritization, interpretation, reporting and trial matching.

Preview

Used and trusted by leading experts

Lucid integrates AI-driven algorithms allowing our team to quickly identify genetic variants and actionable insights with incredible precision. The intuitive interface and seamless collaboration tools have transformed how we analyze and share insights across teams.

Dr. Marco Saverese,
Principal Investigator, Folkhalsan Research Center

Lucid Genomics' cohort analysis tool has been a game changer for our research. It’s intuitive yet powerful, allowing us to quickly compare patient groups and uncover key insights. The platform has streamlined our workflow and enabled faster, data-driven decisions.

Dr. Felix Boschann,
Medical Geneticist, Charité

Lucid cracked 30-year-old unsolved cases — revealing hidden variants and redefining how we see the genome. Simply one of the the best tools to unlock the Dark Genome.

Prof. Pawel Stankiewicz, M.D., Department of Molecular & Human Genetics at Baylor College of Medicine


The Lucid Advantage

Genomics X Multi-Omics

Our platform analyses the whole genome in combination with RNA Seq, Methylation and tissue-specific Epigenetics information.

3D Genome Architecture x TAD regions

Lucid is the only platform that calculates the 3D architecture of the Genome and unlocks deep insights of non-coding regions and the Dark Genome

Cutting edge Science

AI Detection

High-quality detection methods that decrease false-positive structural variants by 81%, including DEL, DUP, INS and INV in comparison to other tools.

AI Prioritization

Disease-agnostic AI tool ranks over 80% of known pathogenic variants in the top 10. We also created a disease-specific scoring system with over 90% accuracy, it ensures precise prioritization for more reliable research outcomes.